1 year agoFirst Alzheimer’s drug to slow disease progression expected to get full FDA approvalJTN2020Verified
1 year agoMax Lugavere on Controversial Alzheimer's Drugs and StudiesThe Joe Rogan Experience Podcast
3 years agoFDA approves Alzheimer’s drug Aduhelm, but concerns raised about cost, effectivenessKNXVVerified
1 year agoWe believe the risk-benefit profile for our Alzheimer’s drug is acceptable, says Eisai U.S. CEOEconomy News
1 year agoYour Healthy Family: Price of new Alzheimer's drug will make it out of reach for manyWFTXVerified
1 year agoNew Alzheimer’s Drug Could Signal Potential Treatment BreakthroughLast World News Channel